EP2190853A4 - Complexes medicamenteux acides de glucosamine exempts d'halogenure - Google Patents

Complexes medicamenteux acides de glucosamine exempts d'halogenure

Info

Publication number
EP2190853A4
EP2190853A4 EP07835861A EP07835861A EP2190853A4 EP 2190853 A4 EP2190853 A4 EP 2190853A4 EP 07835861 A EP07835861 A EP 07835861A EP 07835861 A EP07835861 A EP 07835861A EP 2190853 A4 EP2190853 A4 EP 2190853A4
Authority
EP
European Patent Office
Prior art keywords
halide
acidic drug
drug complexes
free glucosamine
glucosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07835861A
Other languages
German (de)
English (en)
Other versions
EP2190853A1 (fr
Inventor
Vilas M Chopdekar
Michael J Torntore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gluconova LLC
Original Assignee
Gluconova LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gluconova LLC filed Critical Gluconova LLC
Publication of EP2190853A1 publication Critical patent/EP2190853A1/fr
Publication of EP2190853A4 publication Critical patent/EP2190853A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07835861A 2007-06-22 2007-06-22 Complexes medicamenteux acides de glucosamine exempts d'halogenure Withdrawn EP2190853A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/014610 WO2009002297A1 (fr) 2007-06-22 2007-06-22 Complexes medicamenteux acides de glucosamine exempts d'halogenure

Publications (2)

Publication Number Publication Date
EP2190853A1 EP2190853A1 (fr) 2010-06-02
EP2190853A4 true EP2190853A4 (fr) 2011-08-31

Family

ID=40185904

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07835861A Withdrawn EP2190853A4 (fr) 2007-06-22 2007-06-22 Complexes medicamenteux acides de glucosamine exempts d'halogenure

Country Status (3)

Country Link
EP (1) EP2190853A4 (fr)
CA (1) CA2690776A1 (fr)
WO (1) WO2009002297A1 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2413535E (pt) 2010-07-30 2013-01-25 Deutsche Telekom Ag Método para estimar o tipo da estrutura do grupo de imagens de uma pluralidade de fotogramas de vídeo numa sequência de vídeo
WO2014037832A2 (fr) 2012-09-06 2014-03-13 Mahesh Kandula Compositions et méthodes de traitement de l'épilepsie et de maladies neurologiques
SG11201407300VA (en) 2012-05-07 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of neurological disorders
US9399634B2 (en) 2012-05-07 2016-07-26 Cellix Bio Private Limited Compositions and methods for the treatment of depression
WO2013168021A1 (fr) 2012-05-07 2013-11-14 Mahesh Kandula Compositions et méthodes pour le traitement des troubles neuromusculaires et des troubles neurodégénératifs
WO2013167992A1 (fr) 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement de troubles inflammatoires
WO2013168025A1 (fr) 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement des maladies de coagulation du sang
US9434704B2 (en) 2012-05-08 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of neurological degenerative disorders
WO2013168023A1 (fr) 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes pour le traitement de la maladie de parkinson
WO2013167991A1 (fr) 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement de troubles métaboliques
WO2013168003A1 (fr) * 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement de l'inflammation
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
WO2013167999A2 (fr) 2012-05-10 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement d'affections neurologiques
WO2013168014A1 (fr) 2012-05-10 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement de la polyneuropathie amyloïde familiale
US9315478B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
WO2013168012A1 (fr) 2012-05-10 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement de troubles respiratoires
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US9499526B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
WO2013168016A1 (fr) 2012-05-10 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement du syndrome métabolique
WO2013168000A1 (fr) 2012-05-10 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement de la douleur sévère
US9321775B2 (en) 2012-05-10 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of moderate to severe pain
WO2013168015A1 (fr) 2012-05-10 2013-11-14 Mahesh Kandula Compositions et méthodes pour le traitement de l'asthme et de l'allergie
WO2013175376A2 (fr) 2012-05-23 2013-11-28 Mahesh Kandula Compositions et méthodes de traitement de la douleur locale
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
WO2013175347A2 (fr) 2012-05-23 2013-11-28 Mahesh Kandula Compositions et méthodes pour le traitement de troubles respiratoires
WO2013175344A2 (fr) 2012-05-23 2013-11-28 Mahesh Kandula Compositions et méthodes pour le traitement de la parodontite et de la polyarthrite rhumatoïde
CN104603100A (zh) 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
US9765020B2 (en) 2012-05-23 2017-09-19 Cellix Bio Private Limited Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (fr) 2012-08-03 2014-02-06 Mahesh Kandula Compositions et méthodes pour le traitement de la migraine et de maladies neurologiques
US9624168B2 (en) 2012-09-06 2017-04-18 Cellix Bio Private Limited Compositions and methods for the treatment inflammation and lipid disorders
WO2014037834A2 (fr) 2012-09-08 2014-03-13 Mahesh Kandula Compositions et méthodes de traitement d'une inflammation et de troubles lipidiques
CA2800056A1 (fr) 2012-12-24 2014-06-24 Nova Chemicals Corporation Compositions de melange de polyethylene
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
CA2914461A1 (fr) 2013-06-04 2014-12-11 Cellixbio Private Limited Compositions et procedes de traitement du diabete et du pre-diabete
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
WO2016046835A1 (fr) 2014-09-26 2016-03-31 Cellix Bio Private Limited Compositions et méthodes de traitement de l'épilepsie et de troubles neurologiques
CA2967908C (fr) 2014-09-29 2020-11-17 Mahesh Kandula Compositions et methodes pour le traitement de la sclerose en plaques
EP3212626B1 (fr) 2014-10-27 2018-11-07 Cellix Bio Private Limited Séls á trois composants du ester monométhylique du acid fumarique avec pipérazine ou ethylene diamine pour le traitement de sclérose en plaques
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
SG11201705524SA (en) 2015-01-06 2017-08-30 Cellix Bio Private Ltd Compositions and methods for the treatment of inflammation and pain

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604206A (en) * 1990-11-15 1997-02-18 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Complexes containing S(+) phenyl alkane acids and amino sugars
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472380B1 (en) * 1999-11-24 2002-10-29 Jame Fine Chemicals, Inc. Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides
US20070003621A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Dosage forms for movement disorder treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604206A (en) * 1990-11-15 1997-02-18 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Complexes containing S(+) phenyl alkane acids and amino sugars
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009002297A1 *

Also Published As

Publication number Publication date
CA2690776A1 (fr) 2008-12-31
EP2190853A1 (fr) 2010-06-02
WO2009002297A1 (fr) 2008-12-31

Similar Documents

Publication Publication Date Title
EP2190853A4 (fr) Complexes medicamenteux acides de glucosamine exempts d'halogenure
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
GB0709031D0 (en) Pharmaceutical compounds
IL201366A0 (en) Pharmaceutical compounds
EP2133095A4 (fr) Composition pharmaceutique
EP2133094A4 (fr) Composition pharmaceutique
GB0721095D0 (en) Pharmaceutical compounds
EP2191826A4 (fr) Composition pharmaceutique
GB0707087D0 (en) Pharmaceutical compounds
GB0725214D0 (en) Pharmaceutical compounds
EP2224805A4 (fr) Composition pharmaceutique
ZA200806318B (en) Drug combinations
GB0704932D0 (en) Pharmaceutical compounds
GB0721669D0 (en) Pharmaceutical compounds
GB0721332D0 (en) Medicaments
IL197883A0 (en) Combination drug
EP2224808A4 (fr) Composition pharmaceutique
EP2116241A4 (fr) Composition pharmaceutique
GB0700773D0 (en) Drug therapies
GB0606415D0 (en) Topical drug delivery
HK1142774A1 (en) Therapeutic pyrazolonaphthyridine derivatives
EP2156832A4 (fr) Composition pharmaceutique
EP2310022A4 (fr) Médicament topique
EP2224806A4 (fr) Composition pharmaceutique
IL195618A0 (en) Drug administration methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110728

RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 5/06 20060101AFI20110722BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120228